Zimmer Biomet announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2017.
| |
| [18-December-2017] |
| WARSAW, Ind., Dec. 18, 2017 /PRNewswire/ -- Zimmer Biomet (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2017. The cash dividend of $0.24 per share will be paid on or about January 29, 2018 to stockholders of record as of the close of business on December 29, 2017. Future declarations of dividends are subject to approval of the Board of Directors and may be adjusted as business needs or market conditions change. About Zimmer Biomet Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives. We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet. ZBH-Fin View original content with multimedia:http://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-fourth-quarter-of-2017-300572559.html SOURCE Zimmer Biomet Holdings, Inc. | ||
Company Codes: NYSE:ZBH, Swiss:ZBH |
